Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982–3021.

Article  PubMed  PubMed Central  Google Scholar 

Weintraub WS, Daniels SR, Burke LE, Franklin BA, Goff DJ, Hayman LL, et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation. 2011;124:967–90.

Article  CAS  PubMed  Google Scholar 

Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299–304.

Article  PubMed  Google Scholar 

Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21:68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.

Article  CAS  PubMed  Google Scholar 

Lee SH, Kwon HS, Park YM, Ha HS, Jeong SH, Yang HK, et al. Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study. Plos ONE. 2014;9:e90430.

Article  PubMed  PubMed Central  Google Scholar 

Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46:189–97.

Article  PubMed  Google Scholar 

Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med. 2020;18:361.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian X, Zuo Y, Chen S, Liu Q, Tao B, Wu S, et al. Triglyceride-glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort. Cardiovasc Diabetol. 2021;20:19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez-Bello D, Abat M, Alhabib KF, Avezum Á, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 2023;4:e23–e33.

Article  PubMed  Google Scholar 

Rafiee H, Mohammadifard N, Nouri F, Alavi TG, Najafian J, Sadeghi M, et al. Association of triglyceride glucose index with cardiovascular events: insights from the Isfahan Cohort Study (ICS). Eur J Med Res. 2024;29:135.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007-2010 Korean National Health and Nutrition Examination Survey. PLoS ONE. 2019;14:e212963.

Article  Google Scholar 

Yan S, Wang D, Jia Y. Comparison of insulin resistance-associated parameters in US adults: a cross-sectional study. Hormones (Athens). 2023;22:331–41.

Article  PubMed  Google Scholar 

Hu J, Cai X, Li N, Zhu Q, Wen W, Hong J, et al. Association between triglyceride glucose index-waist circumference and risk of first myocardial infarction in Chinese hypertensive patients with obstructive sleep apnoea: an observational cohort study. Nat Sci Sleep. 2022;14:969–80.

Article  PubMed  PubMed Central  Google Scholar 

Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003–2018. Cardiovasc Diabetol. 2024;23:8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. Plos Med. 2015;12:e1001779.

Article  PubMed  PubMed Central  Google Scholar 

Head A, Birkett M, Fleming K, Kypridemos C, O’Flaherty M. Socioeconomic inequalities in accumulation of multimorbidity in England from 2019 to 2049: a microsimulation projection study. Lancet Public Health. 2024;9:e231–e239.

Article  PubMed  Google Scholar 

Pazoki R, Dehghan A, Evangelou E, Warren H, Gao H, Caulfield M, et al. Genetic predisposition to high blood pressure and lifestyle factors: associations with midlife blood pressure levels and cardiovascular events. Circulation. 2018;137:653–61.

Article  PubMed  Google Scholar 

Li FR, Wu KY, Fan WD, Chen GC, Tian H, Wu XB. Long-term exposure to air pollution and risk of incident inflammatory bowel disease among middle and old aged adults. Ecotoxicol Environ Saf. 2022;242:113835.

Article  CAS  PubMed  Google Scholar 

Ma H, Li X, Sun D, Zhou T, Ley SH, Gustat J, et al. Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank. BMJ. 2019;365:l1628.

Article  PubMed  PubMed Central  Google Scholar 

Ortega LS, Bradbury KE, Cross AJ, Morris JS, Gunter MJ, Murphy N. A prospective investigation of body size, body fat composition and colorectal cancer risk in the UK biobank. Sci Rep. 2017;7:17807.

Article  PubMed  PubMed Central  Google Scholar 

Elliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37:234–44.

Article  PubMed  Google Scholar 

Young KG, McGovern AP, Barroso I, Hattersley AT, Jones AG, Shields BM, et al. The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis. Diabetologia. 2023;66:300–9.

Article  CAS  PubMed  Google Scholar 

Cepeda-Valery B, Slipczuk L, Figueredo VM, Pressman GS, Morris DL, Lavie CJ, et al. Association between obesity and infarct size: insight into the obesity paradox. Int J Cardiol. 2013;167:604–6.

Article  PubMed  Google Scholar 

Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17:122.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14:575–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10:293–302.

Article  CAS  PubMed  Google Scholar 

Chen W, Wang S, Lv W, Pan Y. Causal associations of insulin resistance with coronary artery disease and ischemic stroke: a Mendelian randomization analysis. BMJ Open Diabetes Res Care. 2020;8:e001217.

Article  PubMed  PubMed Central  Google Scholar